EX-16.1 2 ex_612250.htm EXHIBIT 16.1 ex_612250.htm

Exhibit 16.1

logo.jpg

 

January 3, 2024

 

Office of the Chief Accountant

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

 

Ladies and Gentlemen:

 

We have read the statements under Item 4.01 of the Current Report on Form 8-K of BioLargo, Inc. to be filed with the Securities and Exchange Commission on or about January 5, 2024. We agree with all statements pertaining to us. We have no basis on which to agree or disagree with the other statements contained therein.

 

 

Very truly yours,

 
  signature.jpg
 

 

HASKELL & WHITE LLP

 

footer.jpg